BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03999749-completion@plaintrial.com
DTSTAMP:20261029T101302Z
DTSTART;VALUE=DATE:20300407
SUMMARY:A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizuma
 b in Combination With Ipilimumab and Nivolumab in Patients With Unresectab
 le Stage III or Stage IV Melanoma — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03999749
URL:https://plaintrial.com/trial/NCT03999749
END:VEVENT
END:VCALENDAR